Literature DB >> 29976083

Panax notoginseng for Inflammation-Related Chronic Diseases: A Review on the Modulations of Multiple Pathways.

Yu Xu1, Hor-Yue Tan1, Sha Li1, Ning Wang1, Yibin Feng1.   

Abstract

Panax notoginseng (P. notoginseng) is a well-known and commonly used Chinese herbal medicine in Asian countries. As one of the major species in the Panax genus, it has a distinct chemical composition and medical application compared with other species. P. notoginseng attracts attention and interest due to its potential therapeutic effects not only on blood diseases, but also other kinds of human chronic disorders. This paper critically reviewed the latest advance of knowledge on the pharmacological effects of P. notoginseng on a variety of chronic diseases including inflammatory bowel disease, arthritis, ischemia, atherosclerosis, Alzheimer disease and trauma, as well as hyperlipidemia, diabetes, and so on. As inflammation is considered the fundamental factor involved in the pathogenesis of chronic diseases, our review therefore focuses on understanding the involvement of classical inflammatory pathways underlying the mechanism of action of P. notoginseng. Potential clinical application was also discussed. Furthermore, by combining with network pharmacology, we introduced the major bioactive components of P. notoginseng, analyzed their cellular targets and associated signaling pathways. In conclusion, this review identified inflammatory pathway as the key signaling for determining the efficacy of P. notoginseng on chronic diseases. It is speculated that P. notoginseng is a multi-targeted agent with an anti-inflammatory property in the adjuvant and alternative treatment of human chronic diseases.

Entities:  

Keywords:  Chronic Diseases; Inflammation; Metabolic Diseases; NF-B; Panax notoginseng; Review

Mesh:

Substances:

Year:  2018        PMID: 29976083     DOI: 10.1142/S0192415X18500519

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  9 in total

1.  Notoginsenoside R1 Regulates Ischemic Myocardial Lipid Metabolism by Activating the AKT/mTOR Signaling Pathway.

Authors:  Wei Lei; Yiqi Yan; Yaolei Ma; Min Jiang; Boli Zhang; Han Zhang; Yuhong Li
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988

Review 2.  Recent advances in nanoplatforms for the treatment of neuropathic pain.

Authors:  Beibei Yu; Kunzhe Wu; Xiaohua Xu; Yan Liu; Jinlan Jiang
Journal:  Spinal Cord       Date:  2022-01-27       Impact factor: 2.473

3.  Yifei Sanjie Formula Treats Chronic Obstructive Pulmonary Disease by Remodeling Pulmonary Microbiota.

Authors:  Yueying Wu; Hui Meng; Bo Qiao; Ning Li; Qiang Zhang; Wenqing Jia; Haijing Xing; Yuqing Li; Jiali Yuan; Zhongshan Yang
Journal:  Front Med (Lausanne)       Date:  2022-06-29

4.  Enhanced Neuroprotective Effects of Panax ginseng G115® and Ginkgo biloba GK501® Combinations In Vitro Models of Excitotoxicity.

Authors:  Elisa Landucci; Domenico E Pellegrini-Giampietro; Anna Rita Bilia; Maria Camilla Bergonzi
Journal:  Int J Mol Sci       Date:  2019-11-22       Impact factor: 5.923

Review 5.  Focus on Notoginsenoside R1 in Metabolism and Prevention Against Human Diseases.

Authors:  Hai Liu; Jianqiong Yang; Wanqing Yang; Shaonan Hu; Yali Wu; Bo Zhao; Haiyan Hu; Shouying Du
Journal:  Drug Des Devel Ther       Date:  2020-02-07       Impact factor: 4.162

6.  Protective effects of the notoginsenoside R1 on acute lung injury by regulating the miR-128-2-5p/Tollip signaling pathway in rats with severe acute pancreatitis.

Authors:  Ju He; Ming-Wei Liu; Zhi-Yi Wang; Rong-Jie Shi
Journal:  Innate Immun       Date:  2022-01       Impact factor: 2.680

7.  Notoginsenoside R1 Ameliorates Cardiac Lipotoxicity Through AMPK Signaling Pathway.

Authors:  Xue Tian; Xu Chen; Qianqian Jiang; Qianbin Sun; Tiantian Liu; Yiqin Hong; Yawen Zhang; Yanyan Jiang; Mingyan Shao; Ran Yang; Chun Li; Qiyan Wang; Yong Wang
Journal:  Front Pharmacol       Date:  2022-03-17       Impact factor: 5.810

8.  Interactions Between Phenolic Acids and Microorganisms in Rhizospheric Soil From Continuous Cropping of Panax notoginseng.

Authors:  Limei Bao; Yuyan Liu; Yafang Ding; Junjie Shang; Yunlin Wei; Yong Tan; Futing Zi
Journal:  Front Microbiol       Date:  2022-02-24       Impact factor: 5.640

9.  New Dammarane-Type Triterpenoid Saponins from Panax notoginseng Leaves and Their Nitric Oxide Inhibitory Activities.

Authors:  Fan Sun; Jingya Ruan; Wei Zhao; Ying Zhang; Guilin Xiang; Jiejing Yan; Mimi Hao; Lijie Wu; Yi Zhang; Tao Wang
Journal:  Molecules       Date:  2019-12-29       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.